
Mittal Diagnostics And Research Centre Private Limited
Provides imaging, lab, and research services for inpatients and health packages.
Provides imaging, lab, and research services for inpatients and health packages.
Mittal Diagnostics And Research Centre Private Limited (MDARCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 July 2006 and has a history of 18 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹1.65 Cr. The company has closed loans amounting to ₹4.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Mittal, Amita Mittal, and Meenal Agrawal serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U85110DL2006PTC188375
188375
Private Limited Indian Non-Government Company
27 Jul 2006
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Mittal ![]() | Managing Director | 27-Jul-2006 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amita Mittal ![]() | Director | 27-Jul-2006 | Current |
Meenal Agrawal ![]() | Director | 17-May-2024 | Current |
Mittal Diagnostics And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.45% increase. The company also saw a substantial improvement in profitability, with a 51.56% increase in profit. The company's net worth Soared by an impressive increase of 14.23%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Mittal Diagnostics And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sunil Mittal is a mutual person
₹1.65 Cr
₹4.74 Cr
Date | Lender | Amount | Status |
---|---|---|---|
29 Jul 2021 | Others | ₹1.65 Cr | Open |
13 Jun 2017 | Others | ₹3.00 Cr | Satisfied |
25 Jan 2011 | Canara Bank | ₹1.13 Cr | Satisfied |
24 May 2010 | Canara Bank | ₹6.10 M | Satisfied |
Mittal Diagnostics And Research Centre has a workforce of 12 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mittal Diagnostics And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mittal Diagnostics And Research Centre's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mittal Diagnostics And Research Centre Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Meenal Agrawal was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 9 months 26 days .
Mittal Diagnostics And Research Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
A charge with Others amounted to Rs. 1.65 Cr with Charge ID 100462605 was registered on 29 Jul 2021.
A charge registered on 13 Jun 2017 via Charge ID 100106980 with Others was fully satisfied on 12 Jul 2021.
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100106980 was registered on 13 Jun 2017.
Mittal Diagnostics And Research Centre Private Limited was incorporated on 27 Jul 2006.
The authorized share capital of Mittal Diagnostics And Research Centre Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 2.00 Cr.
Currently 3 directors are associated with Mittal Diagnostics And Research Centre Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mittal Diagnostics And Research Centre Private Limited is Nu-23A Pitampura India, New Delhi, 110088.
The corporate identification number (CIN) of Mittal Diagnostics And Research Centre Private Limited is U85110DL2006PTC188375 and the company number is 188375 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Mittal Diagnostics And Research Centre Private Limited has risen by 22.45%.
As Per 2022 financial reports, 12 employees are currently employed by Mittal Diagnostics And Research Centre Private Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Mittal Diagnostics And Research Centre Private Limited has experienced an upsurge of 14.23%.
As per the financial statements for fiscal Year 2022, The total open charges for Mittal Diagnostics And Research Centre Private Limited amount to ₹ 1.65 Cr.
The most recent Balance Sheet for Mittal Diagnostics And Research Centre Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.